RESMED INC - 8-K Filing
ResMed Inc. announced an agreement to sell its MatrixCare business for $490 million in cash, expected to close by Q1 FY2027 after regulatory approvals. The divestiture is part of ResMed's strategy to focus on high-growth areas like sleep and connected care; the sale will fund shareholder returns via share repurchases and general corporate purposes. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $RMD